- Home
- JKS vs CATX Comparison
JKS vs CATX Comparison
Compare JKS & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JKS
- CATX
- Stock Information
- Founded
- JKS 2006
- CATX 1983
- Country
- JKS China
- CATX United States
- Employees
- JKS 31030
- CATX N/A
- Industry
- JKS Semiconductors
- CATX Medical/Dental Instruments
- Sector
- JKS Technology
- CATX Health Care
- Exchange
- JKS Nasdaq
- CATX Nasdaq
- Market Cap
- JKS 954.7M
- CATX 782.7M
- IPO Year
- JKS 2010
- CATX N/A
- Fundamental
- Price
- JKS $19.73
- CATX $13.21
- Analyst Decision
- JKS Sell
- CATX Strong Buy
- Analyst Count
- JKS 6
- CATX 6
- Target Price
- JKS $22.46
- CATX $21.40
- AVG Volume (30 Days)
- JKS 633.5K
- CATX 757.8K
- Earning Date
- JKS 10-28-2024
- CATX 08-12-2024
- Dividend Yield
- JKS 7.81%
- CATX N/A
- EPS Growth
- JKS N/A
- CATX N/A
- EPS
- JKS 3.68
- CATX N/A
- Revenue
- JKS $15,379,564,714.00
- CATX $1,464,000.00
- Revenue This Year
- JKS N/A
- CATX N/A
- Revenue Next Year
- JKS $18.30
- CATX N/A
- P/E Ratio
- JKS $5.26
- CATX N/A
- Revenue Growth
- JKS 7.95
- CATX 78.32
- 52 Week Low
- JKS $16.70
- CATX $2.10
- 52 Week High
- JKS $38.65
- CATX $19.10
- Technical
- Relative Strength Index (RSI)
- JKS 52.37
- CATX 52.31
- Support Level
- JKS $17.38
- CATX $14.90
- Resistance Level
- JKS $19.52
- CATX $16.19
- Average True Range (ATR)
- JKS 0.90
- CATX 0.85
- MACD
- JKS 0.26
- CATX -0.11
- Stochastic Oscillator
- JKS 93.97
- CATX 43.22
About JKS JinkoSolar Holding Company Limited (each representing 4)
JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), North America, Europe, Asia Pacific (except China, which includes Hong Kong and Taiwan), and the Rest of the world.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.